Organigram surges 10% on record Q3 results (OGI:NASDAQ)
Organigram Global (OGI) shares jump after record Q3 revenue & EBITDA, boosted by Sanity Group acquisition and margin gains.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
Organigram Global (OGI) shares jump after record Q3 revenue & EBITDA, boosted by Sanity Group acquisition and margin gains.
Organigram surges 10% on record Q3 results (OGI:NASDAQ) | Seeking Alpha
Organigram Global (
OGI
) shares jumped more than 10% on Tuesday after the cannabis company reported fiscal Q3 results.
The company posted record net revenue and adjusted EBITDA, driven in part by its acquisition of Sanity Group. Net revenue rose 49% Y/Y to C$105.8M, while
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
Neuronetics outlines 2026 revenue of $160M-$164M while shifting NeuroStar to broader ownership models (NASDAQ:STIM)
Neuronetics (STIM) Q2 2026 earnings call: revenue +9%, margin expansion, lower OPEX, updated guidance, and NeuroStar leasing shift.
Anthropic models released in EU now embed watermarks on all AI-generated content
Anthropicâs Claude models in the EU will embed watermarks and provenance metadata under the EU AI Act Article 50âsee what changes Aug. 2, 2026.
Altius Minerals Raises Quarterly Dividend 10% to C$0.11, Extending Growth Streak and Signaling Cash Flow Confidence
Altius Minerals increases its quarterly dividend by 10% to C$0.11 per share, continuing its multi-year growth record. This article analyzes its business model, financial health, and industry trends, exploring shareholder return strategies and potential risks for royalty companies.
BIO-key International enters $2.5M warrant inducement transaction (BKYI:NASDAQ)
BIO-key International (BKYI) enters warrant inducement deal to raise ~$2.5M gross proceeds, issuing new warrants pending Nasdaq approval.